UnitedHealth Group Incorporated (UNH) Stake Lowered by QS Investors LLC

QS Investors LLC lessened its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 11.9% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 138,269 shares of the healthcare conglomerate’s stock after selling 18,710 shares during the period. QS Investors LLC’s holdings in UnitedHealth Group were worth $25,638,000 at the end of the most recent reporting period.

Other hedge funds have also recently bought and sold shares of the company. Blue Chip Partners Inc. purchased a new stake in UnitedHealth Group during the second quarter valued at about $110,000. Bruderman Asset Management LLC purchased a new stake in UnitedHealth Group during the second quarter valued at about $114,000. Mitsubishi UFJ Securities Holdings Co. Ltd. grew its position in UnitedHealth Group by 433.3% during the second quarter. Mitsubishi UFJ Securities Holdings Co. Ltd. now owns 640 shares of the healthcare conglomerate’s stock valued at $119,000 after acquiring an additional 520 shares during the period. BDO Wealth Advisors LLC purchased a new stake in UnitedHealth Group during the second quarter valued at about $121,000. Finally, Kings Point Capital Management grew its position in UnitedHealth Group by 27.9% during the first quarter. Kings Point Capital Management now owns 687 shares of the healthcare conglomerate’s stock valued at $113,000 after acquiring an additional 150 shares during the period. 86.20% of the stock is owned by hedge funds and other institutional investors.

In other UnitedHealth Group news, insider Larry C. Renfro sold 50,574 shares of the company’s stock in a transaction that occurred on Friday, September 15th. The stock was sold at an average price of $198.11, for a total transaction of $10,019,215.14. Following the sale, the insider now owns 195,625 shares in the company, valued at $38,755,268.75. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, Director Gail R. Wilensky sold 5,600 shares of the company’s stock in a transaction that occurred on Wednesday, November 29th. The shares were sold at an average price of $223.31, for a total value of $1,250,536.00. Following the sale, the director now owns 61,137 shares in the company, valued at approximately $13,652,503.47. The disclosure for this sale can be found here. In the last quarter, insiders sold 57,606 shares of company stock worth $11,566,525. Insiders own 0.89% of the company’s stock.

UNH has been the subject of a number of research reports. Cowen reissued an “outperform” rating and set a $220.00 price target (up previously from $175.00) on shares of UnitedHealth Group in a research report on Friday, August 11th. Morgan Stanley upped their target price on UnitedHealth Group from $210.00 to $215.00 and gave the stock an “overweight” rating in a research report on Thursday, August 17th. Jefferies Group reaffirmed a “buy” rating and issued a $215.00 target price on shares of UnitedHealth Group in a research report on Friday, August 18th. UBS reaffirmed an “overweight” rating on shares of UnitedHealth Group in a research report on Thursday, August 24th. Finally, Cantor Fitzgerald reaffirmed a “buy” rating on shares of UnitedHealth Group in a research report on Tuesday, August 29th. Three equities research analysts have rated the stock with a hold rating and twenty-four have issued a buy rating to the company’s stock. The company presently has a consensus rating of “Buy” and a consensus target price of $224.56.

UnitedHealth Group Incorporated (NYSE UNH) traded down $1.33 during trading hours on Wednesday, hitting $220.09. The company had a trading volume of 3,246,300 shares, compared to its average volume of 3,119,193. The company has a debt-to-equity ratio of 0.52, a quick ratio of 0.70 and a current ratio of 0.70. UnitedHealth Group Incorporated has a fifty-two week low of $156.09 and a fifty-two week high of $231.77. The firm has a market capitalization of $214,570.92, a PE ratio of 23.07, a price-to-earnings-growth ratio of 1.64 and a beta of 0.66.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Tuesday, October 17th. The healthcare conglomerate reported $2.66 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $2.57 by $0.09. UnitedHealth Group had a return on equity of 21.52% and a net margin of 4.50%. The business had revenue of $50.32 billion for the quarter, compared to analysts’ expectations of $50.38 billion. During the same quarter in the previous year, the firm posted $2.17 earnings per share. The company’s revenue was up 8.7% compared to the same quarter last year. equities research analysts expect that UnitedHealth Group Incorporated will post 9.99 EPS for the current fiscal year.

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, December 12th. Investors of record on Friday, December 1st will be paid a $0.75 dividend. This represents a $3.00 annualized dividend and a dividend yield of 1.36%. The ex-dividend date of this dividend is Thursday, November 30th. UnitedHealth Group’s dividend payout ratio (DPR) is 33.26%.

TRADEMARK VIOLATION NOTICE: This article was posted by Community Financial News and is the property of of Community Financial News. If you are accessing this article on another domain, it was stolen and reposted in violation of US & international trademark and copyright laws. The correct version of this article can be viewed at https://www.com-unik.info/2017/12/06/unitedhealth-group-incorporated-unh-stake-lowered-by-qs-investors-llc.html.

About UnitedHealth Group

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

What are top analysts saying about UnitedHealth Group Incorporated? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for UnitedHealth Group Incorporated and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit